Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chester A Mathis

Showing results (1-10 of 203) with videos related to

Pageof 21
Sort By:
Current Opinion in Neurology|November 8, 2008
The future of amyloid-beta imaging: a tale of radionuclides and tracer proliferationWilliam E Klunk, Chester A Mathis
Nuclear Medicine and Biology|March 21, 2006
Targeting proteins in vivo: in vitro guidelinesWilliam C Eckelman, Chester A Mathis
Neuron|September 21, 2013
Imaging tau deposits in vivo: progress in viewing more of the proteopathy pictureChester A Mathis, William E Klunk
Nuclear Medicine and Biology|February 7, 2006
Molecular targetsWilliam C Eckelman, Chester A Mathis
Neuroimaging Clinics of North America|March 18, 2004
Positron emission tomography radiochemistryN Scott Mason, Chester A Mathis
Alzheimer Disease and Associated Disorders|September 5, 2008
Whatever happened to Pittsburgh Compound-A?William E Klunk, Chester A Mathis
Nuclear Medicine and Biology|March 8, 2024
In vitro evaluation of [<sup>3</sup>H]PI-2620 and structural derivatives in non-Alzheimer's tauopathiesCassis Varlow, Chester A Mathis, Neil Vasdev
Nuclear Medicine and Biology|October 19, 2006
Radiopharmaceutical spaceWilliam C Eckelman, Michael R Kilbourn, Chester A Mathis
Nuclear Medicine and Biology|May 25, 2006
Discussion of targeting proteins in vivo: in vitro guidelinesWilliam C Eckelman, Michael R Kilbourn, Chester A Mathis
Nuclear Medicine and Biology|October 9, 2007
Impact of amyloid imaging on drug development in Alzheimer's diseaseChester A Mathis, Brian J Lopresti, William E Klunk
Pageof 21

Showing results (1-10 of 203) with videos related to

Sort By:
Pageof 21
Current Opinion in Neurology|November 8, 2008
The future of amyloid-beta imaging: a tale of radionuclides and tracer proliferationWilliam E Klunk, Chester A Mathis
Nuclear Medicine and Biology|March 21, 2006
Targeting proteins in vivo: in vitro guidelinesWilliam C Eckelman, Chester A Mathis
Neuron|September 21, 2013
Imaging tau deposits in vivo: progress in viewing more of the proteopathy pictureChester A Mathis, William E Klunk
Nuclear Medicine and Biology|February 7, 2006
Molecular targetsWilliam C Eckelman, Chester A Mathis
Neuroimaging Clinics of North America|March 18, 2004
Positron emission tomography radiochemistryN Scott Mason, Chester A Mathis
Alzheimer Disease and Associated Disorders|September 5, 2008
Whatever happened to Pittsburgh Compound-A?William E Klunk, Chester A Mathis
Nuclear Medicine and Biology|March 8, 2024
In vitro evaluation of [<sup>3</sup>H]PI-2620 and structural derivatives in non-Alzheimer's tauopathiesCassis Varlow, Chester A Mathis, Neil Vasdev
Nuclear Medicine and Biology|October 19, 2006
Radiopharmaceutical spaceWilliam C Eckelman, Michael R Kilbourn, Chester A Mathis
Nuclear Medicine and Biology|May 25, 2006
Discussion of targeting proteins in vivo: in vitro guidelinesWilliam C Eckelman, Michael R Kilbourn, Chester A Mathis
Nuclear Medicine and Biology|October 9, 2007
Impact of amyloid imaging on drug development in Alzheimer's diseaseChester A Mathis, Brian J Lopresti, William E Klunk
Pageof 21